Daily non-political popular news in brief.
Pine tree bark reduces side effects in hypertensive patients
11-15-2006 · EurekAlert!A study published in the October journal of Clinical and Applied Thrombosis/Hemostasis shows Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree reduced edema, a typical side effect of antihypertensive medications, by 36 percent in patients taking these medications.
Read more »
Keywords: pine, tree, bark, side, effects, hypertensive, patients, effect, patient
« Previous | Next »
Similar news on "Pine tree bark reduces side effects in hypertensive patients":
- Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
12-20-2007 · EurekAlert!
The largest study to examine the effect of depression on HIV treatment appears in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The study by Kaiser Permanente and Group Health found depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures but that effective antidepressant medication reverses this outcome. The study looked at 3,359 HIV-infected patients to measure the effects of depression -- with and without SSRIs.
Similar news · Read more »
- Gene patenting -- steep cost for health care and patients
05-07-2007 · EurekAlert!
The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
Similar news · Read more »
- Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
09-18-2007 · EurekAlert!
Provecta demonstrated minimal side effects, significant efficacy and bystander effect on melanoma tumors in stage III patients.
Similar news · Read more »
- Sunshine pill for prostate cancer in 2009
01-16-2007 · EurekAlert!
A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose.
Similar news · Read more »
- Study shows pine bark naturally reduces osteoarthritis knee pain
12-05-2007 · EurekAlert!
A double-blind, placebo-controlled study published in the journal Nutrition Research reveals Pycnogenol, an antioxidant plant extract from the bark of the French maritime pine tree, improved physical function by 52 percent in patients suffering from osteoarthritis of the knee.
Similar news · Read more »
- Pycnogenol delays glucose absorption 190 times more potently than prescription medication
02-07-2007 · EurekAlert!
A new study to be published in an upcoming edition of the journal of Diabetes Research and Clinical Practice reveals that French maritime pine tree extract known as Pycnogenol delays the uptake of glucose from a meal 190 times more than prescription medications, preventing the typical high-glucose peak in the blood stream after a meal. The study revealed the pine bark is more potent for suppressing carbohydrate absorption in diabetes than synthetic prescription alpha-glucosidase inhibitors such as Precose.
Similar news · Read more »
- Researchers propose reason for severe side-effects of Northwick Park clinical trial
01-25-2007 · EurekAlert!
A possible reason why the Northwick Park clinical trial of the drug TGN1412 in the UK caused multiple organ failure in human volunteers is revealed in research presented today at a conference near Paris. The research shows that stimulating the molecule CD28 on cells that mediate the immune response, known as T cells, can have an adverse effect if these immune cells have been activated and altered by infection or illness in the past.
Similar news · Read more »
- Personalized diets may offer relief to advanced cancer patients
03-09-2007 · EurekAlert!
Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
Similar news · Read more »
- St. Jude finds anti-leukemia drug increases patient fatigue
11-01-2007 · EurekAlert!
The anti-leukemia drug dexamethasone contributes to a relentless fatigue and poor quality of sleep in children undergoing treatment for acute lymphoblastic leukemia, according to a new study from St. Jude Children's Research Hospital. The finding suggests that clinicians could improve the quality of life for these children by developing new methods of drug administration that reduce or eliminate these side effects.
Similar news · Read more »
- New study: Pine bark significantly reduces endometriosis
03-07-2007 · EurekAlert!
A new study to be published in an upcoming edition of the Journal of Reproductive Medicine reveals that Pycnogenol, an antioxidant plant extract from the bark of the French maritime pine tree, significantly reduces symptoms of endometriosis by 33 percent.
Similar news · Read more »